Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Microbicide excipients can greatly increase susceptibility to genital herpes transmission in the mouse

  • Thomas R Moench1,
  • Russell J Mumper2,
  • Timothy E Hoen3,
  • Mianmian Sun2 and
  • Richard A Cone3Email author
BMC Infectious Diseases201010:331

DOI: 10.1186/1471-2334-10-331

Received: 31 March 2010

Accepted: 18 November 2010

Published: 18 November 2010

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
31 Mar 2010 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
2 Jun 2010 Reviewed Reviewer Report - Deborah Palliser
26 Jul 2010 Reviewed Reviewer Report - Brian Wigdahl
28 Sep 2010 Author responded Author comments - Richard Cone
Resubmission - Version 3
28 Sep 2010 Submitted Manuscript version 3
28 Sep 2010 Author responded Author comments - Richard Cone
Resubmission - Version 4
28 Sep 2010 Submitted Manuscript version 4
21 Oct 2010 Reviewed Reviewer Report - Brian Wigdahl
28 Oct 2010 Reviewed Reviewer Report - Deborah Palliser
3 Nov 2010 Author responded Author comments - Richard Cone
Resubmission - Version 5
3 Nov 2010 Submitted Manuscript version 5
16 Nov 2010 Author responded Author comments - Richard Cone
Resubmission - Version 6
16 Nov 2010 Submitted Manuscript version 6
Resubmission - Version 7
Submitted Manuscript version 7
Resubmission - Version 8
Submitted Manuscript version 8
Resubmission - Version 9
Submitted Manuscript version 9
Resubmission - Version 10
Submitted Manuscript version 10
17 Nov 2010 Author responded Author comments - Richard Cone
Resubmission - Version 11
17 Nov 2010 Submitted Manuscript version 11
Publishing
18 Nov 2010 Editorially accepted
18 Nov 2010 Article published 10.1186/1471-2334-10-331

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
ReProtect, Inc
(2)
Division of Molecular Pharmaceutics and the Center for Nanotechnology in Drug Delivery, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill
(3)
Johns Hopkins University

Advertisement